Browsing by Author BALRAM CHOWBAY

Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)
2015Association of ABCB1 and FLT3 polymorphisms with toxicities and survival in asian patients receiving sunitinib for renal cell carcinomaChu Y.-H.; Li H. ; Tan H.S.; Koh V.; Lai J.; Phyo W.M.; Choudhury Y.; Kanesvaran R. ; Chau N.M.; Toh C.K.; Ng Q.S.; Tan P.H.; Chowbay B. ; Tan M.-H. 
2013Pharmacogenetics and its relevance to clinical practiceSutiman, N.; Chowbay, B. 
2016Phase I study of oral vinorelbine in combination with erlotinib in advanced non-small cell lung cancer (NSCLC) using two different schedulesSutiman N.; Zhang Z.; Ang M.K. ; Tan S.-W.D.; Toh C.K.; Ng Q.S.; Chowbay B. ; Lim W.-T. 
1-Nov-2008PXR pharmacogenetics: Association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patientsSandanaraj, E.; Lal, S.; Selvarajan, V. ; Ooi, L.L. ; Zee, W.W.; Nan, S.W.; Ang, P.C.S.; Lee, E.J.D. ; Chowbay, B. 
2012SLC22A1-ABCB1 Haplotype Profiles Predict Imatinib Pharmacokinetics in Asian Patients with Chronic Myeloid LeukemiaSingh O.; Chan J.Y.; Lin K.; Heng C.C.T.; Chowbay B. 
May-2003The modulation of irinotecan-induced diarrhoea and pharmacokinetics by three different classes of pharmacologic agentsChowbay, B. ; Sharma, A.; Zhou, Q.-Y.; Cheung, Y.B. ; Lee, E.J.D. 
2010VKORC1 pharmacogenetics and pharmacoproteomics in patients on warfarin anticoagulant therapy: Transthyretin precursor as a potential biomarkerSaminathan R.; Bai J.; Sadrolodabaee L.; Karthik G.M.; Singh O.; Subramaniyan K.; Ching C.B. ; Chen W.N.; Chowbay B.